ES452420A1 - Procedimiento para la obtencion de soluciones solidas de al-caloides del cornezuelo de centeno y sus derivados sinteti- cos. - Google Patents

Procedimiento para la obtencion de soluciones solidas de al-caloides del cornezuelo de centeno y sus derivados sinteti- cos.

Info

Publication number
ES452420A1
ES452420A1 ES452420A ES452420A ES452420A1 ES 452420 A1 ES452420 A1 ES 452420A1 ES 452420 A ES452420 A ES 452420A ES 452420 A ES452420 A ES 452420A ES 452420 A1 ES452420 A1 ES 452420A1
Authority
ES
Spain
Prior art keywords
ergot
alkaholids
polymers
solid solutions
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES452420A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz AG filed Critical Sandoz AG
Publication of ES452420A1 publication Critical patent/ES452420A1/es
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/48Ergoline derivatives, e.g. lysergic acid, ergotamine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Procedimiento para la obtención de soluciones sólidas de alcaloides del cornezuelo de centeno y sus derivados sintéticos, como también sus formas hidrogenadas a sus sales, caracterizado porque comprende las siguientes operaciones: a) disolver el alcaloide del cornezuelo de centeno junto con un polímero elegido de entre polialquilenclicol, polivinilpirrolidona, un copolímero de vinilpirrolidona y acetato de vinilo o una mezcla de los mismos en un disolvente común, tal como un alcohol inferior, particularmente metanol o etanol, bajo agitación y a una temperatura comprendida entre 30 y 70ºC, preferentemente comprendida entre 40 y 70ºC, hasta la obtención de una solución clara; b) eliminar el disolvente bajo vacío a una temperatura comprendida entre 30 y 70ºC, preferentemente comprendida entre 40 y 70ºC; c) dejar solidificar la solución clara resultante a temperatura comprendida entre 15 y 25ºC; d) moler el sólido resultante a un polvo fino y eliminar todas las trazas de disolvente por secadospreferiblemente bajo vacío a una temperatura de 30ºC aproximadamente.
ES452420A 1975-10-17 1976-10-15 Procedimiento para la obtencion de soluciones solidas de al-caloides del cornezuelo de centeno y sus derivados sinteti- cos. Expired ES452420A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2546577A DE2546577B2 (de) 1975-10-17 1975-10-17 Feste Stoffe aus Polyvinylpyrrolidon und Ergotalkaloiden

Publications (1)

Publication Number Publication Date
ES452420A1 true ES452420A1 (es) 1978-04-16

Family

ID=5959411

Family Applications (1)

Application Number Title Priority Date Filing Date
ES452420A Expired ES452420A1 (es) 1975-10-17 1976-10-15 Procedimiento para la obtencion de soluciones solidas de al-caloides del cornezuelo de centeno y sus derivados sinteti- cos.

Country Status (28)

Country Link
JP (1) JPS5854122B2 (es)
AT (1) AT362510B (es)
AU (1) AU508628B2 (es)
BE (1) BE847368A (es)
CA (1) CA1079641A (es)
CH (1) CH643737A5 (es)
CS (1) CS199647B2 (es)
DE (1) DE2546577B2 (es)
DK (1) DK146194C (es)
ES (1) ES452420A1 (es)
FI (1) FI762875A (es)
FR (1) FR2327764A1 (es)
GB (1) GB1560406A (es)
GR (1) GR61268B (es)
HK (1) HK3183A (es)
HU (1) HU172533B (es)
IE (1) IE43778B1 (es)
IL (1) IL50686A (es)
MY (1) MY8400063A (es)
NL (1) NL184558C (es)
NO (1) NO144468C (es)
NZ (1) NZ182341A (es)
PH (1) PH14513A (es)
PT (1) PT65719B (es)
SE (1) SE430379B (es)
SG (1) SG63082G (es)
SU (1) SU1165223A3 (es)
ZA (1) ZA766166B (es)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1572226A (en) * 1977-11-03 1980-07-30 Hoechst Uk Ltd Pharmaceutical preparations in solid unit dosage form
US4411882A (en) 1978-12-21 1983-10-25 Sandoz Ltd. Galenical compositions
WO1980001242A1 (en) * 1978-12-21 1980-06-26 Sandoz Ag Galenical preparation
FR2454804B1 (fr) * 1979-04-26 1986-11-21 Sanofi Sa Medicament a base de dihydroergotoxine et son procede de preparation
US4366145A (en) * 1981-06-24 1982-12-28 Sandoz, Inc. Soft gelatin capsule with a liquid ergot alkaloid center fill solution and method of preparation
US4898729A (en) * 1983-12-09 1990-02-06 Euroceltique, S.A. Treatment of hypertension, compounds and compositions for antihypertension and diuresis
HU198844B (en) * 1984-06-14 1989-12-28 Sandoz Ag Process for producing new galenic pharmaceutical composition ensuring retarded release of active ingredient
ATE72111T1 (de) * 1987-01-14 1992-02-15 Ciba Geigy Ag Therapeutisches system fuer schwerloesliche wirkstoffe.
FR2610827B1 (fr) * 1987-02-18 1991-09-13 Pf Medicament Comprime de dihydroergotamine (d.h.e.) du type a matrice hydrophile et son procede de fabrication
US5064656A (en) * 1989-11-14 1991-11-12 Dr. Gergely & Co. Uncoated pharmaceutical reaction tablet
DE4401646A1 (de) * 1994-01-21 1995-07-27 Krewel Werke Gmbh Optimal freisetzende Kava-Extrakte
US6524832B1 (en) 1994-02-04 2003-02-25 Arch Development Corporation DNA damaging agents in combination with tyrosine kinase inhibitors
US6632455B2 (en) 1997-12-22 2003-10-14 Schering Corporation Molecular dispersion composition with enhanced bioavailability
NZ504834A (en) * 1997-12-22 2001-12-21 Schering Corp Tricyclic amide molecular dispersion composition with enhanced bioavailability
US6316462B1 (en) 1999-04-09 2001-11-13 Schering Corporation Methods of inducing cancer cell death and tumor regression
US7771746B2 (en) 1999-12-03 2010-08-10 Polichem Sa Methods for making sustained-release pharmaceutical compositions of ergot alkaloids having improved bioavailability and compositions thereof
WO2001039742A2 (en) * 1999-12-03 2001-06-07 Polichem S.A. Methods for making sustained-release pharmaceutical compositions of ergot alkaloids having improved bioavailability and compositions thereof
US7135436B2 (en) 2003-05-05 2006-11-14 J.F. Daley International, Ltd. Solid algicide, preparation and usage in recirculating water
AU2003304242A1 (en) * 2003-06-27 2005-01-13 Bioprogress S.P.A. Composite product obtainable by cogrinding of a active principle with a copolymer n-vinyl-2-pyrrolidone/vinyl-acetate

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1175430A (en) * 1966-04-07 1969-12-23 Sandoz Ltd Pharmaceutical Compositions containing Ergot Alkaloids

Also Published As

Publication number Publication date
NZ182341A (en) 1978-09-20
IE43778L (en) 1977-04-17
JPS5251014A (en) 1977-04-23
NO144468C (no) 1981-09-09
ZA766166B (en) 1978-05-30
FR2327764B1 (es) 1979-03-02
DK146194B (da) 1983-07-25
NL7611295A (nl) 1977-04-19
DK454176A (da) 1977-04-18
FR2327764A1 (fr) 1977-05-13
SU1165223A3 (ru) 1985-06-30
BE847368A (fr) 1977-04-15
IE43778B1 (en) 1981-05-20
HK3183A (en) 1983-01-20
SE430379B (sv) 1983-11-14
ATA767976A (de) 1980-10-15
GR61268B (en) 1978-10-17
NO763446L (es) 1977-04-19
GB1560406A (en) 1980-02-06
DK146194C (da) 1984-01-02
CS199647B2 (en) 1980-07-31
PT65719B (fr) 1978-06-12
SG63082G (en) 1983-09-09
NL184558C (nl) 1989-09-01
SE7611189L (sv) 1977-04-18
PT65719A (fr) 1976-11-01
IL50686A (en) 1979-05-31
NL184558B (nl) 1989-04-03
FI762875A (es) 1977-04-18
PH14513A (en) 1981-08-24
AU1875476A (en) 1978-04-20
AT362510B (de) 1981-05-25
JPS5854122B2 (ja) 1983-12-02
NO144468B (no) 1981-06-01
IL50686A0 (en) 1976-12-31
HU172533B (hu) 1978-09-28
MY8400063A (en) 1984-12-31
CH643737A5 (en) 1984-06-29
CA1079641A (en) 1980-06-17
DE2546577A1 (de) 1977-04-21
AU508628B2 (en) 1980-03-27
DE2546577B2 (de) 1981-04-02

Similar Documents

Publication Publication Date Title
ES452420A1 (es) Procedimiento para la obtencion de soluciones solidas de al-caloides del cornezuelo de centeno y sus derivados sinteti- cos.
JPS5265551A (en) Composition containing partially hydrogenated block copolymers and article produced thereby
IL49229A0 (en) Novel polyamines,their preparation and their use as stabilizers for polyolefine compositions
PH12974A (en) 6,7-benzomorphan derivatives and their pharmaceutical composition
IL49022A0 (en) Isoxazolylbenzamide derivatives,their production and pharmaceutical compositions containing them
GB1544647A (en) 2-piperidinoalkyl-1-benzofurans-1,4-benzodioxans and 1,4-benzoxathians process for their manufacture and pharmaceutical preparations containing them
IL49411A0 (en) Phenylalkane-carboxylic acid derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
IL50932A (en) Carbo(hetero)bicyclic ethanolamine derivatives,process for their preparation and pharmaceutical compositions containing them
HU177823B (en) Rodenticide composition containing n-alkyl-2,4-dinitro-6-trifluoromethyl-diphenyl-amine derivatives and process for producing the active agents
JPS51127011A (en) Composition based on polyamine having ether group and process for preparing same
IL49447A0 (en) Novel lysergic acid amides,their preparation and pharmaceutical compositions containing them
IL50736A0 (en) Phenoxyalkylcarboxylic acid derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
IL50091A (en) 4-substituted-2-oxazolidinones,their production and pharmaceutical compositions containing them
GB1524611A (en) 1,3-butanediol mono - (3' -hydroxybutyrates) and process for their manufacture
CS194774B2 (en) Process for preparing derivatives of 1,4-dihydropyridine suitable especially as antihypertensive and antianginar medicament
IL48863A (en) 3-substituted phenyl-alkyl amine derivatives,their preparation and pharmaceutical compositions comprising them
IL49668A (en) Stable solutions of hydrogenated ergopeptide alkaloids,their preparation and pharmaceutical composition comprising them
ZA761538B (en) 13,14-dehydro-11deoxy-prostaglandins and process for their preparation
JPS5217434A (en) Novel compound*process for preparation thereof and pharmaceutical composition
GR60551B (en) Pharmaceutical compositions containing heterocolloidal debrycin and process for the preparation thereof
GR60560B (en) Penicillines,preparation process and use thereof as medicines
IL49277A0 (en) New isoquinoline derivatives,their production and pharmaceutical compositions containing them
IL51104A (en) 4a-phenyl-isoquinoline derivatives,their production and pharmaceutical compositions containing them
IL49766A0 (en) Novel isoquinoline derivatives,their production and pharmaceutical compositions containing them
IL49806A0 (en) Benzocycloheptathiophene derivatives,their production and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19990503